Ambrx Biopharma, Inc. - Common Stock (NY:AMAM)

N/A UNCHANGED

Last Price Updated: 7:00 PM EDT, Mar 16, 2023 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	10.66 (3)
Ask (Size)	11.24 (1)
Prev. Close	10.13
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Dividend Stocks That Are Too Good to Ignore: Q1 Edition ↗

February 26, 2024

Here are the three dividend stocks that will never disappoint you. Buy them while they trade at a discount.

Via InvestorPlace

3 Stocks to Buy That Are Up 200% or More in 2024 ↗

February 23, 2024

Each of these stocks up 200% in 2024 offer unique upside opportunities for investors, including equity arbitrage plays.

Via InvestorPlace

Performance

More News

The 3 Biotech Stocks That Could Make Your February Unforgettable ↗

February 15, 2024

Via InvestorPlace

AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM

February 10, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Looking Into Ambrx Biopharma's Recent Short Interest ↗

January 29, 2024

Via Benzinga

Assessing Ambrx Biopharma: Insights From 7 Financial Analysts ↗

January 09, 2024

Via Benzinga

Health Care Company Johnson & Johnson Announces Merger With Ambrx Biopharma ↗

January 08, 2024

Via Benzinga

Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson ↗

January 27, 2024

Via The Motley Fool

Johnson & Johnson Secures Complete FDA Approval For Bladder Cancer Drug Balversa, After Almost Five Years Of Accelerated Approval ↗

January 22, 2024

Via Benzinga

Johnson & Johnson's Q4 Earnings: Spotlight On Dividend Security Following Kenvue Split, Legal Costs, Acquisitions ↗

January 22, 2024

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)

January 16, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week ↗

January 13, 2024

Via Talk Markets

Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗

January 12, 2024

Via Investor's Business Daily

AMBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM

January 10, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

January 09, 2024

Via FinancialNewsMedia

January 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

January 09, 2024

From FN Media Group LLC

Via GlobeNewswire

Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results ↗

January 08, 2024

Via Benzinga

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 08, 2024

Via Benzinga

Crude Oil Falls Sharply; Ambrx Biopharma Shares Spike Higher ↗

January 08, 2024

Via Benzinga

Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today? ↗

January 08, 2024

Via InvestorPlace

Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal ↗

January 08, 2024

Via Benzinga

US Stocks Mixed; Nasdaq Jumps Over 100 Points ↗

January 08, 2024

Via Benzinga

J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value ↗

January 08, 2024

Via Investor's Business Daily

Frequently Asked Questions

Is Ambrx Biopharma, Inc. - Common Stock publicly traded?

Yes, Ambrx Biopharma, Inc. - Common Stock is publicly traded.

What exchange does Ambrx Biopharma, Inc. - Common Stock trade on?

Ambrx Biopharma, Inc. - Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Ambrx Biopharma, Inc. - Common Stock?

The ticker symbol for Ambrx Biopharma, Inc. - Common Stock is AMAM on the New York Stock Exchange